Navigation Links
Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Date:5/18/2009

Non-drug Procedure for Asthma Highlighted at ATS 2009

SUNNYVALE, Calif., May 18 /PRNewswire/ -- Results of the Asthma Intervention Research 2 (AIR2) Trial of the Alair(R) Bronchial Thermoplasty System, developed by Asthmatx, Inc., were announced today at ATS 2009, the International Conference of the American Thoracic Society, in San Diego, Calif. The AIR2 results demonstrated statistically significant improvements in quality of life measurements, reductions in asthma attacks (severe exacerbations) and emergency room visits for respiratory symptoms in adults with severe asthma who underwent bronchial thermoplasty delivered by the Alair System.

"The reduction in asthma attacks and improvements in quality of life are consistent with the outcomes from previous trials," said Mario Castro, MD, Professor of Medicine and Pediatrics at the Washington University School of Medicine, and a Principal Investigator in the AIR2 Trial. "These outcomes provide further clinical evidence needed to demonstrate the safety, effectiveness and long term benefits of bronchial thermoplasty."

The AIR2 Trial was designed to evaluate the safety and effectiveness of bronchial thermoplasty in adult patients with severe asthma who were symptomatic, despite being treated with high doses of standard of care medications (high dose inhaled corticosteroids and long-acting bronchodilators). The study was a randomized, double-blind, sham-controlled trial and enrolled 297 patients at 30 sites in 6 countries. The primary effectiveness endpoint was the change from baseline in Asthma Quality of Life Questionnaire (AQLQ) score. Safety was assessed by comparing the short and long-term safety profiles for both the treatment and sham control groups.

Key statistically significant clinical findings of the AIR2 Trial were:

  • Improvement in the average AQLQ score at 6-, 9-, and 12 months over sha
    '/>"/>

SOURCE Asthmatx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
2. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
3. Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
4. Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
5. QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
6. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
7. Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
8. VirtualScopics Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial
9. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
10. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
11. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... (Nasdaq: DRRX ) announced today financial results for the ... net loss was $5.5 million for the three months ended ... million and net loss of $5.5 million for the three ... cash and investments of $37.8 million, compared to cash and ... 30, 2015, we had $19.8 million in long term debt. ...
(Date:8/3/2015)... 2015 Par Pharmaceutical Companies, Inc. announced today ... August 7, 2015 at 9:00 a.m. EDT to review ... June 30, 2015.  Par is privately held and currently ... its filings with the Securities and Exchange Commission and ... by following the instructions at http://www.parpharm.com/financialinfo .  Par ...
(Date:8/3/2015)... YORK , Aug. 3, 2015   ... global pharmaceutical company Allergan plc is ... Deloitte and Intermountain Healthcare to include ... harness ConvergeHEALTH,s OutcomesMiner analytics platform to generate real-world ... outcomes. "We look forward to expanding ...
Breaking Medicine Technology:DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 3ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 4
... RAPIDS, Mich., May 31, 2011 The Neuroblastoma ... the opening of a first-of-its-kind genomic-based clinical trial ... relapsed and refractory neuroblastoma. The ... (VARI), is a nationwide network of pediatric cancer ...
... Life Technologies Corporation  (NASDAQ: LIFE ) today ... RNA-Seq Kit for the Ion Personal Genome Machine (PGM™) ... to microarrays for transcript expression analysis. The Ion PGM ... enabling scientists to get far more accurate and comprehensive ...
Cached Medicine Technology:Consortium Opens Landmark Personalized Medicine Children's Cancer Trial 2Ion Torrent Ships New RNA Sequencing Application as Fast, Easy, Affordable Alternative to Microarrays 2Ion Torrent Ships New RNA Sequencing Application as Fast, Easy, Affordable Alternative to Microarrays 3Ion Torrent Ships New RNA Sequencing Application as Fast, Easy, Affordable Alternative to Microarrays 4
(Date:8/4/2015)... ... 2015 , ... Mr Didier Cauchois, CIO of information systems ... , Mr Cauchois attributes the success to the dedication from the team at ... technology offered by Winscribe's platform. , "We have already begun to see ...
(Date:8/3/2015)... ... August 04, 2015 , ... The ... a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She ... 700,000 members and over 200 operating Local Chapters, NAPW is the nation’s leading ...
(Date:8/3/2015)... ... August 04, 2015 , ... The American ... , The new internationally peer-reviewed Guidelines were prepared by members of the AAT ... imaging, in evaluating patients with dental-oral and systemic health-related complaints. , Thermography ...
(Date:8/3/2015)... , ... August 03, 2015 , ... sweetFrog Enterprises, LLC. ... location is the 20th sweetFrog store operating in the Lone Star State. The premium ... growing companies in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, ...
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data Interchange ( ... create efficiencies in healthcare information exchange, announced the release of its findings from its ... Services (HHS) Secretary, WEDI shared survey results and recommendations , strongly ...
Breaking Medicine News(10 mins):Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:National Association of Professional Women Inducts Armethia Holt, CEO at AA&G Group Homes, LLC, Into its VIP Woman of the Year Circle 2Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 2Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 3Health News:sweetFrog Reopens Texas Store Today 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4
... of altruism; helping others ... one,s own health issues, CHICAGO, May 15 Meet Cindy Zamirowski, ... "cancer,free" thumbs up from her physician, stepped off the curb to raise ... The Bolingbrook mom of three and grandma of three rallied her ...
... to a new study from the University of Minnesota, the ... have been identified. The researchers found that the point of ... in receptor molecules, molecular "hooks" on the outer surface of ... of the bloodstream. The research appears in the May 15 ...
... ORLANDO, FL, May 20, 2008- Maxi-K gene therapy may ... whose erectile dysfunction (ED) is not treatable with oral ... Scientific Meeting of the American Urological Association (AUA) may ... to reporters in a special press conference on May ...
... FL, May 20, 2008 Transplantation of muscle-derived ... treatment for patients suffering from urinary incontinence following ... the 103rd Annual Scientific Meeting of the American ... resulting from iatrogenic sphincter damage may benefit from ...
... May 21, 2008Men aged 75-80 with prostate-specific antigen (PSA) ... discontinue their regular prostate cancer screenings, according to new ... the American Urological Association (AUA). Johns Hopkins University researchers ... a PSA level of 3 ng/ml or above had ...
... U.S. Hospitals, ANN ARBOR, Mich., May 14 ... 13 hospitals for excellence in,performance improvement at the ... the 2008 awards were announced during the Thomson,Reuters ... Resort,in Orlando, Florida., Temple University Health System ...
Cached Medicine News:Health News:After Effects: Giving Back Is Good for You 2Health News:U of Minnesota researcher discovers the starting point of sun-induced skin cancer 2Health News:AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment 2Health News:Regular prostate-specific antigen screening may be discontinued in certain elderly populations 2Health News:Thomson Reuters Honors Temple University Health System for Initiative That Cut Costs $64 Million and Grew Clinical Service Lines 2
... semiconductor-based laser system representing the latest in technological ... for fast treatment of large areas (14 mm ... High power and large spot size optimize laser ... indicated for the treatment of vascular and pigmented ...
The Perkins has been established for well over 20 years as a "world standard" for hand held applanation tonometers....
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
Medicine Products: